<DOC>
	<DOCNO>NCT00259610</DOCNO>
	<brief_summary>The purpose study 1 ) determine well treat early RA patient methotrexate combination hydroxychloroquine plus sulfasalazine combination etanercept reserve treatment patient appropriately respond methotrexate alone 2 ) determine combination methotrexate therapy well</brief_summary>
	<brief_title>Treatment Early Aggressive Rheumatoid Arthritis ( TEAR )</brief_title>
	<detailed_description>The ultimate goal RA eliminate symptom , restore patient normal physical , social , emotional , vocational function , preserve structure integrity joint . While disease modify anti-rheumatic drug ( DMARDs ) long cornerstone RA therapy , limitation DMARDs become increasingly apparent investigator continue gain insight pathogenesis disease . Recent evidence suggest treatment earlier disease process aggressive approach result superior long-term outcome compare less intensive treatment regimen . Specifically , grow interest possibility early `` aggressive '' treatment combination DMARDs initial treatment effort potentially reduce proportion patient advance severe disability .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<mesh_term>Sulfasalazine</mesh_term>
	<criteria>Have diagnosis RA less equal 3 year Be 18 year age old time diagnosis Pregnant lactate woman History chronic infection , hepatitis , pneumonia , chronic skin infection Active TB evidence latent TB</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>RA</keyword>
	<keyword>painful joint</keyword>
	<keyword>swollen joint</keyword>
</DOC>